GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 35 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $30,395,000 | +6.4% | 698,242 | +6.5% | 0.05% | +23.1% |
Q1 2022 | $28,562,000 | +3.3% | 655,704 | +4.6% | 0.04% | +5.4% |
Q4 2021 | $27,657,000 | +20.1% | 627,154 | +4.1% | 0.04% | +8.8% |
Q3 2021 | $23,031,000 | +14.1% | 602,742 | +18.9% | 0.03% | +13.3% |
Q2 2021 | $20,191,000 | -16.9% | 507,023 | -25.6% | 0.03% | -25.0% |
Q1 2021 | $24,306,000 | +5.3% | 681,034 | +8.6% | 0.04% | -2.4% |
Q4 2020 | $23,074,000 | -15.1% | 627,008 | -13.2% | 0.04% | -26.8% |
Q3 2020 | $27,183,000 | +7.8% | 722,191 | +16.8% | 0.06% | -3.4% |
Q2 2020 | $25,214,000 | -2.9% | 618,143 | -9.7% | 0.06% | -19.4% |
Q1 2020 | $25,954,000 | -37.8% | 684,859 | -22.8% | 0.07% | -17.2% |
Q4 2019 | $41,711,000 | +13.3% | 887,551 | +2.9% | 0.09% | -7.4% |
Q3 2019 | $36,801,000 | +6.2% | 862,469 | -0.4% | 0.09% | +5.6% |
Q2 2019 | $34,650,000 | +19.2% | 865,771 | +24.4% | 0.09% | +8.5% |
Q1 2019 | $29,076,000 | -6.9% | 696,074 | -14.8% | 0.08% | -18.8% |
Q4 2018 | $31,240,000 | -5.9% | 816,991 | -1.1% | 0.10% | +6.3% |
Q3 2018 | $33,193,000 | -0.3% | 826,478 | -0.1% | 0.10% | -6.9% |
Q2 2018 | $33,297,000 | +0.2% | 826,954 | -2.7% | 0.10% | -2.9% |
Q1 2018 | $33,234,000 | +16.7% | 849,604 | +5.9% | 0.10% | +16.7% |
Q4 2017 | $28,480,000 | -22.9% | 802,457 | -11.9% | 0.09% | -29.7% |
Q3 2017 | $36,941,000 | -6.6% | 910,345 | -0.8% | 0.13% | -12.3% |
Q2 2017 | $39,555,000 | -3.9% | 917,957 | -6.0% | 0.15% | -8.2% |
Q1 2017 | $41,153,000 | +19.7% | 976,388 | +9.5% | 0.16% | +8.9% |
Q4 2016 | $34,374,000 | -19.6% | 891,343 | -10.1% | 0.15% | -24.0% |
Q3 2016 | $42,770,000 | +82.1% | 991,330 | +82.9% | 0.19% | +76.1% |
Q2 2016 | $23,486,000 | +24.5% | 541,871 | +16.5% | 0.11% | +9.0% |
Q1 2016 | $18,859,000 | +3.2% | 465,301 | +2.7% | 0.10% | +5.3% |
Q4 2015 | $18,274,000 | -58.7% | 452,989 | -60.6% | 0.10% | -61.8% |
Q3 2015 | $44,239,000 | -51.7% | 1,150,859 | -47.8% | 0.25% | +3.8% |
Q2 2015 | $91,585,000 | +87.6% | 2,203,762 | +108.3% | 0.24% | -10.1% |
Q1 2015 | $48,824,000 | +17.1% | 1,058,133 | +8.5% | 0.27% | +15.1% |
Q4 2014 | $41,679,000 | -1.9% | 975,200 | +5.5% | 0.23% | -37.8% |
Q3 2014 | $42,479,000 | +29.0% | 924,066 | +50.1% | 0.37% | +26.0% |
Q2 2014 | $32,934,000 | +8.8% | 615,824 | +8.8% | 0.30% | +2.1% |
Q1 2014 | $30,274,000 | – | 565,942 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |